These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3185637)

  • 21. Green enzymes and suicide substrates: a look at the acyl-CoA dehydrogenases in fatty acid oxidation.
    Thorpe C
    Trends Biochem Sci; 1989 Apr; 14(4):148-51. PubMed ID: 2658223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal onset of medium-chain acyl-coenzyme A dehydrogenase deficiency with confusing biochemical features.
    Christodoulou J; Hoare J; Hammond J; Ip WC; Wilcken B
    J Pediatr; 1995 Jan; 126(1):65-8. PubMed ID: 7815228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems in the detection of fatty acid oxidation defects: experience of a quality assurance programme for qualitative urinary organic acid analysis.
    Downing M; Allen JC; Bonham JR; Edwards RG; Manning NJ; Olpin SE; Pollitt RJ
    J Inherit Metab Dis; 1999 May; 22(3):289-92. PubMed ID: 10384389
    [No Abstract]   [Full Text] [Related]  

  • 25. Uptake, distribution, and oxidation of fatty acids by Leishmania mexicana amastigotes.
    Berman JD; Gallalee JV; Best JM; Hill T
    J Parasitol; 1987 Jun; 73(3):555-60. PubMed ID: 3037056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic crisis in an infant--is the problem in the mitochondria?].
    Tyni T; Pihko H
    Duodecim; 2002; 118(13):1331-9. PubMed ID: 12239878
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatty acid oxidation defects as causes of unexpected death in infancy.
    Bennett MJ; Allison F; Pollitt RJ; Variend S
    Prog Clin Biol Res; 1990; 321():349-64. PubMed ID: 2326299
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical and biochemical variation and family studies in the multiple acyl-CoA dehydrogenation disorders.
    Rhead WJ; Wolff JA; Lipson M; Falace P; Desai N; Fritchman K; Moon A; Sweetman L
    Pediatr Res; 1987 Apr; 21(4):371-6. PubMed ID: 3574988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of carnitine in intracellular metabolism.
    Bremer J
    J Clin Chem Clin Biochem; 1990 May; 28(5):297-301. PubMed ID: 2199593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and properties of short-chain acyl-CoA, medium-chain acyl-CoA, and isovaleryl-CoA dehydrogenases from human liver.
    Finocchiaro G; Ito M; Tanaka K
    Adv Neurol; 1988; 48():221-30. PubMed ID: 3334784
    [No Abstract]   [Full Text] [Related]  

  • 33. Nephrotoxicity and hepatotoxicity of 5,6-dichloro-4-thia-5-hexenoic acid: evidence for fatty acid beta-oxidation-dependent bioactivation.
    Fitzsimmons ME; Baggs RB; Anders MW
    J Pharmacol Exp Ther; 1994 Oct; 271(1):515-23. PubMed ID: 7965751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Structure and evolution of enzymes involved in fatty acid oxidation].
    Sato S; Kawaguchi A
    Seikagaku; 1996 Nov; 68(11):1692-703. PubMed ID: 8976144
    [No Abstract]   [Full Text] [Related]  

  • 35. Defects of fatty acid oxidation in skeletal muscle.
    Turnbull DM; Bartlett K; Watmough NJ; Shepherd IM; Sherratt HS
    J Inherit Metab Dis; 1987; 10 Suppl 1():105-12. PubMed ID: 3119934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects in mitochondrial beta-oxidation of fatty acids.
    Wood PA
    Curr Opin Lipidol; 1999 Apr; 10(2):107-12. PubMed ID: 10327278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspected defect in fatty acid oxidation.
    Truscott R; Pullin C; Halpern B; Wilcken B; Silink M; Griffiths H; Kilham H; Grunseit F
    N Engl J Med; 1978 Jul; 299(3):152. PubMed ID: 661878
    [No Abstract]   [Full Text] [Related]  

  • 38. Organic acid profiles resembling a beta-oxidation defect in two patients with coeliac disease.
    Costa CG; Verhoeven NM; Kneepkens CM; Douwes AC; Wanders RJ; de Almeida IT; Duran M; Jakobs C
    J Inherit Metab Dis; 1996; 19(2):177-80. PubMed ID: 8739959
    [No Abstract]   [Full Text] [Related]  

  • 39. Current research in the organic acidurias.
    Chalmers RA
    J Inherit Metab Dis; 1989; 12(2):225-39. PubMed ID: 2502680
    [No Abstract]   [Full Text] [Related]  

  • 40. Recurrent acute encephalopathy due to fatty acid metabolic defect--report of two cases.
    Chen CH; Chi CC; Shu NY
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):284-9. PubMed ID: 1646679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.